Giampaolo Merlini Selected Research

Amyloid Plaque

1/2021	Age-related amyloidosis outside the brain: A state-of-the-art review.
12/2020	Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee.
1/2020	Amyloidosis and Ocular Involvement: an Overview.
10/2018	Systemic immunoglobulin light chain amyloidosis.
5/2018	Novel Therapies in Light Chain Amyloidosis.
1/2018	Light Chain Amyloidosis.
1/2018	European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.
1/2018	Proteomics with Mass Spectrometry Imaging: Beyond Amyloid Typing.
1/2018	New concepts in the treatment and diagnosis of amyloidosis.
12/2017	AL amyloidosis: from molecular mechanisms to targeted therapies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giampaolo Merlini Research Topics

Disease

133	Amyloidosis 09/2022 - 03/2002
106	Immunoglobulin Light-chain Amyloidosis 12/2022 - 03/2002
33	Amyloid Plaque 01/2021 - 03/2002
19	Multiple Myeloma 01/2021 - 01/2004
18	Transthyretin-Related Hereditary Amyloidosis 11/2021 - 06/2012
18	Cardiomyopathies (Cardiomyopathy) 01/2021 - 05/2003
15	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2017 - 04/2003
14	Paraproteinemias (Monoclonal Gammopathy) 12/2022 - 08/2002
12	Polyneuropathies (Polyneuropathy) 06/2021 - 05/2003
8	Proteinuria 01/2021 - 06/2007
7	Disease Progression 09/2022 - 03/2005
7	Heart Failure 01/2021 - 05/2003
7	Familial Amyloidosis (Hereditary Amyloidosis) 01/2019 - 05/2004
7	Neoplasms (Cancer) 01/2019 - 01/2007
6	Renal Insufficiency (Renal Failure) 11/2014 - 04/2003
5	Cardiotoxicity 01/2020 - 07/2013
5	Infections 01/2020 - 03/2005
5	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 07/2005
5	Proteostasis Deficiencies 10/2018 - 04/2004
5	Peripheral Nervous System Diseases (PNS Diseases) 12/2017 - 04/2003
5	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 06/2017 - 12/2012
5	Monoclonal Gammopathy of Undetermined Significance 01/2016 - 04/2003
4	Rare Diseases (Rare Disease) 01/2019 - 12/2005
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016 - 01/2009
3	Pain (Aches) 04/2020 - 06/2013
3	Lymphadenopathy 01/2020 - 04/2003
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019 - 07/2007
3	Inflammation (Inflammations) 05/2017 - 01/2007
3	Cytopenia 08/2014 - 01/2005
3	Alzheimer Disease (Alzheimer's Disease) 09/2013 - 10/2005
3	Weight Loss (Weight Reduction) 03/2013 - 04/2003
3	Fever (Fevers) 01/2013 - 04/2003
3	Cryoglobulinemia 01/2009 - 04/2003
2	Lymphoma (Lymphomas) 01/2021 - 01/2005
2	autosomal dominant familial Periodic fever 01/2021 - 04/2015
2	Rheumatoid Arthritis 01/2020 - 01/2012
2	Liver Diseases (Liver Disease) 01/2019 - 12/2005
2	Frailty 05/2018 - 11/2016
2	POEMS Syndrome (Syndrome, POEMS) 12/2017 - 08/2013

Drug/Important Bio-Agent (IBA)

85	Amyloid (Amyloid Fibrils)IBA 12/2022 - 06/2002
59	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2002
39	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2022 - 06/2002
37	Prealbumin (Transthyretin)IBA 09/2022 - 06/2002
24	Bortezomib (Velcade)FDA Link 01/2022 - 10/2007
23	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2004
22	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2011
16	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019 - 06/2002
14	Immunoglobulin M (IgM)IBA 01/2017 - 01/2005
10	Amyloidogenic ProteinsIBA 01/2020 - 06/2002
10	pro-brain natriuretic peptide (1-76)IBA 11/2016 - 05/2003
9	Pharmaceutical PreparationsIBA 09/2022 - 04/2004
9	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2013
8	AA amyloidosisIBA 01/2020 - 09/2004
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 05/2003
7	Thalidomide (Thalomid)FDA Link 01/2022 - 01/2004
7	CreatinineIBA 01/2022 - 03/2002
7	daratumumabIBA 01/2022 - 01/2020
7	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 03/2005
7	Lenalidomide (CC 5013)FDA Link 01/2022 - 01/2012
7	tafamidisIBA 01/2021 - 12/2013
6	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021 - 06/2002
5	C-Reactive ProteinIBA 01/2021 - 01/2007
4	AntibodiesIBA 01/2021 - 01/2016
4	Proteasome InhibitorsIBA 01/2021 - 01/2016
4	AntigensIBA 01/2020 - 08/2003
4	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 07/2010
4	Rituximab (Mabthera)FDA Link 01/2017 - 01/2005
4	Blood Proteins (Serum Proteins)IBA 01/2007 - 04/2003
3	AlbuminsIBA 01/2022 - 01/2007
3	Monoclonal AntibodiesIBA 01/2021 - 01/2018
3	GelsolinIBA 01/2020 - 05/2004
3	Congo RedIBA 01/2018 - 07/2009
3	ApolipoproteinsIBA 05/2015 - 12/2006
3	Troponin IIBA 05/2014 - 03/2009
2	ixazomibIBA 01/2022 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2009
2	pomalidomideIBA 12/2020 - 01/2017
2	InotersenIBA 04/2020 - 07/2018
2	Radioisotopes (Radionuclides)IBA 01/2020 - 11/2019
2	Muramidase (Lysozyme)IBA 01/2019 - 05/2004
2	Apolipoprotein C-II (ApoC2)IBA 01/2019 - 02/2017
2	patisiranIBA 01/2019 - 01/2019
2	Bendamustine Hydrochloride FDA Link 11/2018 - 01/2017
2	Peptides (Polypeptides)IBA 02/2017 - 08/2008
2	Alkylating AgentsIBA 01/2017 - 03/2013
2	ParaproteinsIBA 10/2016 - 10/2014
2	GlycosaminoglycansIBA 01/2016 - 04/2004

Therapy/Procedure

67	Therapeutics 09/2022 - 03/2002
11	Drug Therapy (Chemotherapy) 07/2022 - 07/2005
4	Liver Transplantation 09/2022 - 06/2016
4	Stem Cell Transplantation 04/2014 - 04/2004
4	Renal Dialysis (Hemodialysis) 09/2013 - 11/2005
3	Kidney Transplantation 01/2019 - 07/2005
3	Salvage Therapy 01/2017 - 01/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 09/2010
2	Activities of Daily Living (ADL) 04/2020 - 11/2016
2	Aftercare (After-Treatment) 01/2020 - 11/2010
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019 - 01/2012
2	Radiotherapy 09/2017 - 06/2013